The important metabolic function of gluconeogenesis is an exclusive property of kidney and liver. Renal gluconeogenesis has been characterized with respect to its substrates and physiological, hormonal and ionic modulators. It is evident that the major physiologic determinants of renal gluconeogenesis appear to act on the synthesis of the rate limiting enzyme on gluconeogenesis; phosphoenolpyruvate carboxykinase (PEPCK). It has become evident that PEPC synthesis is regulated at the level of nuclear transcription of PEPCK messenger RNA (mRNA). In addition to providing glucose, gluconeogenesis appears to be related to and pemissive for renal ammonaigenesis; a key process in the renal adaptation to an increased acid load. Although ammoniagenesis has been studied in the setting of the remnant kidney, there is little information on the adaptation of gluconeogenesis in the remnant kidney. We plan to impose a physiologic stimulus; acute metabolic acidosis, and to document a sequence of events culminating in renal gluconeogenesis; a physiologic response. This sequence of events; nuclear PEPCK mRNA transcription, increased cytoplasmic PEPCK mRNA, increased PEPCK enzymatic activity and finally, increased gluconeogenesis, forms a paradigm of the normal physiologic response. In applying these measurements to the model of progressive renal ablation, we will manipulate the major regulators of renal gluconeogenesis; dietary protein, and adrenal and the parthyroid status. The following methods will be used: 50-75%nephrectomy, adrenalectomy, parathyroidectomy, measurements of: nuclear PEPCK mRNA transcription and cytoplasmic mRNA levels, PEPCK activity and gluconeogenesis. Our results will address several questions: 1)-Is the gluconeogenic respone to an acid load altered in renal insufficiency, and if so is it in proportion to: a)-The degree of rnal insufficiency? b)-The degre of renal ammoniagenic response? 2)-Does dietary protein intake modify renal gluconeogenesis as it does ammoniagenesis? a)-If so, does it depend on hyperfiltration? 3)-Does adrenal hormone secretion condition the renal gluconeogenic response in normal and remnant kidneys? 4)-Is parathyroid hormone secretion premissive for renal gluconeogenesis in normal and remnant kidneys? 5)-Are altrations in renal gluconeogenic response a reflection of altered PEPCK mRNA synthesis at the nuclear level, at the level of PEPCK mRNA stability, at the expression of PEPCK activity or at another level of renal metabolism?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK031398-06
Application #
3230046
Study Section
General Medicine B Study Section (GMB)
Project Start
1983-04-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Mahimkar, Rajeev M; Visaya, Orvin; Pollock, Allan S et al. (2005) The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins. Biochem J 385:461-8
Pollock, Allan S; Turck, Johanna; Lovett, David H (2003) The prodomain of interleukin 1alpha interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells. FASEB J 17:203-13
Mahimkar, R M; Baricos, W H; Visaya, O et al. (2000) Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney. J Am Soc Nephrol 11:595-603
Jabrane-Ferrat, N; Pollock, A S; Goetzl, E J (2000) Inhibition of expression of the type I G protein-coupled receptor for vasoactive intestinal peptide (VPAC1) by hammerhead ribozymes. Biochemistry 39:9771-7
Tanney, D C; Feng, L; Pollock, A S et al. (1998) Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Dev Dyn 213:121-9
Mertens, P R; Alfonso-Jaume, M A; Steinmann, K et al. (1998) A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 273:32957-65
Turck, J; Pollock, A S; Lovett, D H (1997) Gelatinase A is a glomerular mesangial cell growth and differentiation factor. Kidney Int 51:1397-400
Reddy, D; Pollock, A S; Clark, S A et al. (1997) Transfection and overexpression of the calcium binding protein calbindin-D28k results in a stimulatory effect on insulin synthesis in a rat beta cell line (RIN 1046-38). Proc Natl Acad Sci U S A 94:1961-6
Mertens, P R; Harendza, S; Pollock, A S et al. (1997) Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem 272:22905-12
Turck, J; Pollock, A S; Lee, L K et al. (1996) Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 271:15074-83

Showing the most recent 10 out of 21 publications